Post-operative Monitoring of Gastric Cancer

Suzhou Huhu Health & Technology Inc.

Status

Enrolling

Conditions

Gastric Cancer

Treatments

Diagnostic Test: DNA test

Study type

Observational

Funder types

Other

Industry

Identifiers

NCT07026240

2311285-6（1）

Details and patient eligibility

About

This study is to determine the performance of non-invasive new multi-target biomarkers in the post-operative monitoring of gastric cancer.

Full description

This study aims to develop and validate a new non-invasive detection method for postoperative monitoring of gastric cancer in the blood. Blood will also be collected at various time points post-operatively. We will determine whether these new biomarkers can be used as prognostic biomarkers to predict tumor recurrence and metastasis. We will also determine whether these new biomarkers detect tumor recurrence and metastasis earlier than methods currently used in the clinic such as imaging and tumor biomarkers CA19-9, CEA, and CA72-4.

This study is a prospective and multi-center study.

Enrollment

258 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subject age over 18.
Subject has stomach discomfort, and seek medical attention at the Gastric Surgery Department of our center.
Subject has or will have gastroscopy and/or pathological examination results at this center.
Subject must be able to fully understand the informed consent form and be able to personally sign it.

Exclusion criteria

Subject has serious heart, liver, kidney dysfunction, or mental illness.
Subject diagnosed previously with any kind of malignant tumor.
Subject is known to be infected with HIV or other related diseases (considering interference from the use of immune drugs).
Subject is receiving targeted drugs, immunosuppressants, immunomodulators, and biological therapies.
Researchers believe that subject is not suitable for enrollment.
Subject can not supply sufficient sample to complete this experiment.